Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Oncolink Library / Journal Scans / Breast Cancer
Inger Thune, Tormod Brenn, Eiliv Lund, Maria Gaard
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001
Reviewers: Kenneth Blank, M.D. and John Chang, M.D.
Source: The New England Journal of Medicine -- May 1, 1997 -- Volume 336, Number 18
Strong evidence exists tying estrogen exposure to breast cancer. For example, women who have early menopause, late menarche and low parity are at increased risk for breast cancer. In fact, some researches believe that endogenous sex hormones are the key to understanding the etiology of breast cancer. Physical activity may alter the metabolism of estrogen and therefore may influence a women's risk of breast cancer. Several studies have examined the association of exercise and breast cancer risk but no firm conclusions can be drawn from these studies most of which are small and with limited follow up. A recent study reported in the New England Journal of medicine overcomes these shortcomings and helps establish a more definitive link between the risk of breast cancer and physical activity.
From 1974 to 1983 the National Health Screening Service in Norway entered 25,624 women in a national program aimed at better defining factors that contribute to women's health. Participants were aged 20-54 at study entry and were asked to complete health surveys and questionnaires about leisure time and work physical activity. During the follow up period 351 study participants were diagnosed with breast cancer. Analysis of the questionnaires found that greater leisure time activity reduced the risk of breast cancer. Specifically, women who exercised regularly had a 37% reduction in the risk of breast cancer. This association held even after adjusting for other breast cancer risk factors including body mass and parity. The reduction was lowest in lean women, women who continued to exercise for 3-5 years and women under the age of 45. These findings support the conclusions from many smaller reports documenting a the protective effect of physical activity - although a few studies have not found exercise to lower breast cancer risk.
Several mechanisms may explain the study's findings:
Whether this study provides conclusive evidence of a link between sedentary life style and breast cancer is debatable as the study has several flaws including the failure to account for factors such as smoking, alcohol intake and dietary variations. Exploration of the biologic mechanisms are needed as are further prospective randomized trials. However, it is clear that regular physical activity provides several health benefits including reducing the risk of heart attacks, strokes and diabetes and should be strongly recommended by all physicians to their patients- females and male alike.
Dr. Wein discusses prostate cancer, screening and treatment options. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

